The federal government has allocated $8.7 million to boost the life sciences and biomanufacturing industry in Prince Edward Island. This funding aims to address labor challenges in the sector, which is anticipated to continue expanding, particularly in the production of pharmaceuticals, vaccines, and health-related products.
The Canadian Alliance for Skills and Training in Life Sciences (CASTL) will receive the funding through Ottawa’s Sectoral Workforce Solutions Program. CASTL, which has training facilities in Prince Edward Island, Quebec, and British Columbia, plays a crucial role in developing and reinforcing the workforce to meet the industry’s demands amidst global disruptions.
Charlottetown MP Sean Casey emphasized the importance of enhancing the workforce in response to the sector’s significant needs and economic demands. He highlighted the necessity to prepare for the growth trajectory expected in the coming years, with an estimated 65,000 additional professionals required in Canada’s biomanufacturing and biotech workforce by 2029.
Penny Walsh, the CEO of CASTL, stated that the funding will support training initiatives for individuals entering or already employed in biomanufacturing, including post-secondary students and current employees seeking skills advancement. She emphasized the critical role of CASTL’s facilities as simulated manufacturing plants, enabling trainees to practice technical tasks safely in a heavily regulated industry.
Regarding the Island’s economic benefits, Rory Francis, former CEO of the P.E.I. BioAlliance and departing CASTL board chair, highlighted the positive impact of CASTL’s national success on the local economy. He emphasized that having a state-of-the-art training facility in Prince Edward Island enhances the competitiveness of local companies and attracts international businesses to the region.